补充钙和维生素D与主动脉瓣狭窄长期死亡率的关系
这项回顾性纵向研究纳入2008至2016年克利夫兰诊所超声心动图数据库中≥60岁轻中度原生主动脉瓣狭窄患者2657例,随访至2018年。结果显示,补充钙±维生素D与全因死亡、心血管死亡和主动脉瓣置换风险显著升高相关,而任何补充剂均与AS参数纵向变化无关。
要点
- 补充钙±维生素D与全因死亡风险升高相关(HR=1.31)。
- 补充钙±维生素D与心血管死亡风险升高相关(HR=2.0)。
- 补充钙±维生素D与主动脉瓣置换风险升高相关(HR=1.48)。
核心结论
- 在老年轻中度原生主动脉瓣狭窄患者中,补充钙±维生素D与较低的生存率和较高的主动脉瓣置换率相关。
研究设计与样本
- 回顾性纵向研究,纳入2008至2016年克利夫兰诊所超声心动图数据库中年龄≥60岁的轻中度原生主动脉瓣狭窄患者2657例,随访至2018年。
主要发现
- 中位随访69个月,补充钙±维生素D与全因死亡风险显著升高相关(绝对发生率43.0/1000人年;HR=1.31,95%CI 1.07-1.62;p=0.009)。
- 补充钙±维生素D与心血管死亡风险显著升高相关(绝对发生率13.7/1000人年;HR=2.0,95%CI 1.31-3.07;p=0.001)。
- 补充钙±维生素D与主动脉瓣置换风险显著升高相关(绝对发生率88.2/1000人年;HR=1.48,95%CI 1.24-1.78;p<0.001)。
- 线性混合效应模型显示,任何补充剂均与AS参数的纵向变化无关。
临床怎么用
- 对于老年轻中度主动脉瓣狭窄患者,处方钙±维生素D补充剂时应权衡长期生存和瓣膜置换风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Calcium metabolism has long been implicated in aortic stenosis (AS). Studies assessing the long-term safety of oral calcium and/or vitamin D in AS are scarce yet imperative given the rising use among an elderly population prone to deficiency. We sought to identify the associations between supplemental calcium and vitamin D with mortality and progression of AS. METHODS: In this retrospective longitudinal study, patients aged ≥60 years with mild-moderate native AS were selected from the Cleveland Clinic Echocardiography Database from 2008 to 2016 and followed until 2018. Groups were stratified into no supplementation, supplementation with vitamin D alone and supplementation with calcium±vitamin D. The primary outcomes were mortality (all-cause, cardiovascular (CV) and non-CV) and aortic valve replacement (AVR), and the secondary outcome was AS progression by aortic valve area and peak/mean gradients. RESULTS: Of 2657 patients (mean age 74 years, 42% women) followed over a median duration of 69 months, 1292 (49%) did not supplement, 332 (12%) took vitamin D alone and 1033 (39%) supplemented with calcium±vitamin D. Calcium±vitamin D supplementation was associated with a significantly higher risk of all-cause mortality (absolute rate (AR)=43.0/1000 person-years; HR=1.31, 95% CI (1.07 to 1.62); p=0.009), CV mortality (AR=13.7/1000 person-years; HR=2.0, 95% CI (1.31 to 3.07); p=0.001) and AVR (AR=88.2/1000 person-years; HR=1.48, 95% CI (1.24 to 1.78); p<0.001). Any supplementation was not associated with longitudinal change in AS parameters in a linear mixed-effects model. CONCLUSIONS: Supplemental calcium with or without vitamin D is associated with lower survival and greater AVR in elderly patients with mild-moderate AS.
引用
- Kassis N, Hariri EH, Karrthik AK, et al. Supplemental calcium and vitamin D and long-term mortality in aortic stenosis. Heart. 2022. PMID: 35470234. doi:10.1136/heartjnl-2021-320215
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。